Sjogren's syndrome-associated meningoencephalomyelitis: Cerebrospinal fluid cytokine levels and therapeutic utility of tacrolimus

Takayuki Hoshina, Yui Yamaguchi, Shouichi Ohga, Ryutaro Kira, Masataka Ishimura, Hidetoshi Takada, Tamami Tanaka, Toshiro Hara

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Serial changes in the circulating and cerebrospinal fluid (CSF) cytokine levels were assessed in a patient with Sjogren's syndrome (SS)-associated meningoencephalomyelitis. A 16-yr-old girl diagnosed as having primary SS at 8 yr of age presented headache and vomiting. CSF studies revealed lymphocyte-dominant pleocytosis and high IgM index, but no evidence of infection. Disturbed consciousness and diffuse slow waves on electroencephalogram led to the diagnosis of SS-meningoencephalitis. The clinical condition subsided after a cycle of dexamethasone therapy, however, 2 months later urinary retention and paresthesia of the lower body developed. Craniospinal magnetic resonance imaging (MRI) showed extensive intraparenchymal lesions with high T2-weighted signal intensity adjacent to the posterior left horn of lateral ventricle of the brain and the longitudinal lesion from C5 to T10 of the spinal cord. High-dose methyl-prednisolone and subsequent tacrolimus therapy has effectively controlled the activity of SS-meningoencephalomyelitis. Monitoring of systemic and CSF cytokine levels during the course of illness revealed that CSF interleukin-6, but not interferon-γ or tumor necrosis factor-α levels were the sensitive indicator of disease activity. The unique cytokine profile, differing from those of infectious meningitis may be useful for predicting the central nervous system involvement in autoimmune disease.

Original languageEnglish
Pages (from-to)182-186
Number of pages5
JournalJournal of the Neurological Sciences
Volume267
Issue number1-2
DOIs
Publication statusPublished - Apr 15 2008

Fingerprint

Sjogren's Syndrome
Tacrolimus
Cerebrospinal Fluid
Cytokines
Meningoencephalitis
Urinary Retention
Paresthesia
Lateral Ventricles
Leukocytosis
Therapeutics
Horns
Prednisolone
Consciousness
Meningitis
Interferons
Dexamethasone
Autoimmune Diseases
Vomiting
Immunoglobulin M
Headache

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Sjogren's syndrome-associated meningoencephalomyelitis : Cerebrospinal fluid cytokine levels and therapeutic utility of tacrolimus. / Hoshina, Takayuki; Yamaguchi, Yui; Ohga, Shouichi; Kira, Ryutaro; Ishimura, Masataka; Takada, Hidetoshi; Tanaka, Tamami; Hara, Toshiro.

In: Journal of the Neurological Sciences, Vol. 267, No. 1-2, 15.04.2008, p. 182-186.

Research output: Contribution to journalArticle

Hoshina, Takayuki ; Yamaguchi, Yui ; Ohga, Shouichi ; Kira, Ryutaro ; Ishimura, Masataka ; Takada, Hidetoshi ; Tanaka, Tamami ; Hara, Toshiro. / Sjogren's syndrome-associated meningoencephalomyelitis : Cerebrospinal fluid cytokine levels and therapeutic utility of tacrolimus. In: Journal of the Neurological Sciences. 2008 ; Vol. 267, No. 1-2. pp. 182-186.
@article{24ba4a35b57342c2a6bef571c21667df,
title = "Sjogren's syndrome-associated meningoencephalomyelitis: Cerebrospinal fluid cytokine levels and therapeutic utility of tacrolimus",
abstract = "Serial changes in the circulating and cerebrospinal fluid (CSF) cytokine levels were assessed in a patient with Sjogren's syndrome (SS)-associated meningoencephalomyelitis. A 16-yr-old girl diagnosed as having primary SS at 8 yr of age presented headache and vomiting. CSF studies revealed lymphocyte-dominant pleocytosis and high IgM index, but no evidence of infection. Disturbed consciousness and diffuse slow waves on electroencephalogram led to the diagnosis of SS-meningoencephalitis. The clinical condition subsided after a cycle of dexamethasone therapy, however, 2 months later urinary retention and paresthesia of the lower body developed. Craniospinal magnetic resonance imaging (MRI) showed extensive intraparenchymal lesions with high T2-weighted signal intensity adjacent to the posterior left horn of lateral ventricle of the brain and the longitudinal lesion from C5 to T10 of the spinal cord. High-dose methyl-prednisolone and subsequent tacrolimus therapy has effectively controlled the activity of SS-meningoencephalomyelitis. Monitoring of systemic and CSF cytokine levels during the course of illness revealed that CSF interleukin-6, but not interferon-γ or tumor necrosis factor-α levels were the sensitive indicator of disease activity. The unique cytokine profile, differing from those of infectious meningitis may be useful for predicting the central nervous system involvement in autoimmune disease.",
author = "Takayuki Hoshina and Yui Yamaguchi and Shouichi Ohga and Ryutaro Kira and Masataka Ishimura and Hidetoshi Takada and Tamami Tanaka and Toshiro Hara",
year = "2008",
month = "4",
day = "15",
doi = "10.1016/j.jns.2007.10.009",
language = "English",
volume = "267",
pages = "182--186",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Sjogren's syndrome-associated meningoencephalomyelitis

T2 - Cerebrospinal fluid cytokine levels and therapeutic utility of tacrolimus

AU - Hoshina, Takayuki

AU - Yamaguchi, Yui

AU - Ohga, Shouichi

AU - Kira, Ryutaro

AU - Ishimura, Masataka

AU - Takada, Hidetoshi

AU - Tanaka, Tamami

AU - Hara, Toshiro

PY - 2008/4/15

Y1 - 2008/4/15

N2 - Serial changes in the circulating and cerebrospinal fluid (CSF) cytokine levels were assessed in a patient with Sjogren's syndrome (SS)-associated meningoencephalomyelitis. A 16-yr-old girl diagnosed as having primary SS at 8 yr of age presented headache and vomiting. CSF studies revealed lymphocyte-dominant pleocytosis and high IgM index, but no evidence of infection. Disturbed consciousness and diffuse slow waves on electroencephalogram led to the diagnosis of SS-meningoencephalitis. The clinical condition subsided after a cycle of dexamethasone therapy, however, 2 months later urinary retention and paresthesia of the lower body developed. Craniospinal magnetic resonance imaging (MRI) showed extensive intraparenchymal lesions with high T2-weighted signal intensity adjacent to the posterior left horn of lateral ventricle of the brain and the longitudinal lesion from C5 to T10 of the spinal cord. High-dose methyl-prednisolone and subsequent tacrolimus therapy has effectively controlled the activity of SS-meningoencephalomyelitis. Monitoring of systemic and CSF cytokine levels during the course of illness revealed that CSF interleukin-6, but not interferon-γ or tumor necrosis factor-α levels were the sensitive indicator of disease activity. The unique cytokine profile, differing from those of infectious meningitis may be useful for predicting the central nervous system involvement in autoimmune disease.

AB - Serial changes in the circulating and cerebrospinal fluid (CSF) cytokine levels were assessed in a patient with Sjogren's syndrome (SS)-associated meningoencephalomyelitis. A 16-yr-old girl diagnosed as having primary SS at 8 yr of age presented headache and vomiting. CSF studies revealed lymphocyte-dominant pleocytosis and high IgM index, but no evidence of infection. Disturbed consciousness and diffuse slow waves on electroencephalogram led to the diagnosis of SS-meningoencephalitis. The clinical condition subsided after a cycle of dexamethasone therapy, however, 2 months later urinary retention and paresthesia of the lower body developed. Craniospinal magnetic resonance imaging (MRI) showed extensive intraparenchymal lesions with high T2-weighted signal intensity adjacent to the posterior left horn of lateral ventricle of the brain and the longitudinal lesion from C5 to T10 of the spinal cord. High-dose methyl-prednisolone and subsequent tacrolimus therapy has effectively controlled the activity of SS-meningoencephalomyelitis. Monitoring of systemic and CSF cytokine levels during the course of illness revealed that CSF interleukin-6, but not interferon-γ or tumor necrosis factor-α levels were the sensitive indicator of disease activity. The unique cytokine profile, differing from those of infectious meningitis may be useful for predicting the central nervous system involvement in autoimmune disease.

UR - http://www.scopus.com/inward/record.url?scp=39049146972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049146972&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2007.10.009

DO - 10.1016/j.jns.2007.10.009

M3 - Article

C2 - 17996906

AN - SCOPUS:39049146972

VL - 267

SP - 182

EP - 186

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -